Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.

about

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.Value of Supportive Care Pharmacogenomics in Oncology Practice.Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists.

P2860

Q44587107-6C11AB0A-C063-4DA7-96A0-BA6AE851FE62 Q52603826-32210C3D-BEF3-4AC4-A607-AB5FE2D284BE Q55666180-A2457C5E-099C-4227-8EA8-D933E551E813

P2860

Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.

Item

http://www.wikidata.org/entity/Q38731079

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Personalizing supportive care ...... tic-driven treatment pathways.

@en

type

Item

label

Personalizing supportive care ...... tic-driven treatment pathways.

@en

prefLabel

Personalizing supportive care ...... tic-driven treatment pathways.

@en

P1476

Personalizing supportive care ...... tic-driven treatment pathways.

@en

P2093

Daniel J Johnson

http://www.w3.org/2001/XMLSchema#string

Jai N Patel

http://www.w3.org/2001/XMLSchema#string

Rebecca L Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics

Clinical implementation of germ line cancer pharmacogenetic variants during the next-generation sequencing era.

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.

Pharmacogenetics: from bench to byte--an update of guidelines.

Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.

P304

417-434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.15.178

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26871520

http://www.w3.org/2001/XMLSchema#string

Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.

about

P2860

P2860

Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698